Cargando…
The Potential of Ferroptosis-Targeting Therapies for Alzheimer’s Disease: From Mechanism to Transcriptomic Analysis
Alzheimer’s disease (AD), the most common form of dementia, currently affects 40–50 million people worldwide. Despite the extensive research into amyloid β (Aβ) deposition and tau protein hyperphosphorylation (p-tau), an effective treatment to stop or slow down the progression of neurodegeneration i...
Autores principales: | Majerníková, Nad’a, den Dunnen, Wilfred F. A., Dolga, Amalia M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8721139/ https://www.ncbi.nlm.nih.gov/pubmed/34987375 http://dx.doi.org/10.3389/fnagi.2021.745046 |
Ejemplares similares
-
Corrigendum: The Potential of Ferroptosis-Targeting Therapies for Alzheimer's Disease: From Mechanism to Transcriptomic Analysis
por: Majerníková, Nad'a, et al.
Publicado: (2022) -
Neuropathological Diagnostic Considerations in Hyperkinetic Movement Disorders
por: den Dunnen, Wilfred F. A.
Publicado: (2013) -
Negative modulation of mitochondrial calcium uniporter complex protects neurons against ferroptosis
por: Marmolejo-Garza, Alejandro, et al.
Publicado: (2023) -
Iron Metabolism, Ferroptosis, and the Links With Alzheimer’s Disease
por: Yan, Nao, et al.
Publicado: (2020) -
Machine learning models identify ferroptosis-related genes as potential diagnostic biomarkers for Alzheimer’s disease
por: Deng, Yanyao, et al.
Publicado: (2022)